CEPID 2001-2013
CEPID 2013-2024

WEBSITE: http://cibfar.ifsc.usp.br

Principal Investigator: Glaucius Oliva 
Education and Knowledge Diffusion Coordinator: Leila Maria Beltramini 
Technology Transfer Coordinator: Adriano Defini Andricopulo 

University of São Paulo (USP)
Instituto de Física de São Carlos
Av. João Dagnone, 1.100
13563-120 - São Carlos, SP - Brasil

Federal University of São Carlos (UFSCar)
São Paulo State University (UNESP)
State University of Campinas (UNICAMP)

Center leaflet (pdf):

Center for Research and Innovation in Biodiversity and Drug Discovery

Discovery facilitates search for drug to sabotage replication of SARS-CoV-2

Scientists at CIBFar investigated the mechanism that produces the main enzyme involved in the virus’s replication in cells. The findings are reported in the Journal of Molecular Biology

Sirius helps scientists look for COVID-19 drugs in first experiment

Partnering with CNPEM, CIBFar researchers used the protein crystallography beamline to analyze more than 200 protein crystals from the novel coronavirus as they were exposed to tiny fragments of widely used drugs. If a compound fits perfectly into a target protein, its action can be blocked in the virus

Researchers seek antiviral molecules for the treatment of COVID-19

Synthetic compounds and molecules derived from natural products belonging to Brazil’s biodiversity are being screened by teams at the Center for Innovation in Biodiversity and Drug Discovery.

Consortium vows to find new drugs against Chagas disease, leishmaniosis and malaria

Initiative supported by FAPESP, USP, UNICAMP and global partners sets out to discover new molecules against tropical parasitic diseases. Its aim is to develop effective and affordable drugs.

Deciphering biological structures in search of medicines

Glaucius Oliva speaks at FAPESP Week London about the line of work of the Center for Research and Innovation in Biodiversity and Drug Discovery and how the UK collaboration helps developing structural biology in Brazil.

Neglected diseases continue to require attention despite progress

Few novel drugs have been developed to treat neglected diseases in recent decades, Brazilian researchers warn.

Scientists synthesize molecule capable of eliminating hepatitis C virus

The compound called GA-Hecate also acts on bacteria, fungi and cancer cells and will be tested against Zika and yellow fever viruses.

New molecule considered promising antimalarial candidate

Molecule designed by the Center for Research and Innovation in Biodiversity and Drug Discovery killed malaria parasite in mice and in vitro culture.